KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Current Taxes (2016 - 2024)

Zimmer Biomet Holdings has reported Current Taxes over the past 16 years, most recently at $70.3 million for Q1 2024.

  • For Q1 2024, Current Taxes rose 50.86% year-over-year to $70.3 million; the TTM value through Mar 2024 reached $70.3 million, up 50.86%, while the annual FY2023 figure was $61.2 million, 58.96% up from the prior year.
  • Current Taxes for Q1 2024 was $70.3 million at Zimmer Biomet Holdings, up from $61.2 million in the prior quarter.
  • Over five years, Current Taxes peaked at $121.9 million in Q2 2020 and troughed at $30.4 million in Q3 2022.
  • A 5-year average of $67.9 million and a median of $61.2 million in 2023 define the central range for Current Taxes.
  • Biggest five-year swings in Current Taxes: plummeted 74.92% in 2022 and later surged 219.41% in 2023.
  • Year by year, Current Taxes stood at $59.5 million in 2020, then increased by 4.2% to $62.0 million in 2021, then tumbled by 37.9% to $38.5 million in 2022, then surged by 58.96% to $61.2 million in 2023, then grew by 14.87% to $70.3 million in 2024.
  • Business Quant data shows Current Taxes for ZBH at $70.3 million in Q1 2024, $61.2 million in Q4 2023, and $97.1 million in Q3 2023.